Clinical trials
Phase 2 Borderline Personality Disorder trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2007 | 1 |
| 2010 | 3 |
| 2013 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Terminated | 4 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Chicago | 4 |
| Yale University | 4 |
| Boehringer Ingelheim | 1 |
| Columbia Northwest Pharmaceuticals | 1 |
| Indiana University | 1 |
| Ohio State University | 1 |
| Oryzon Genomics S.A. | 1 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 |
| State University of New York - Upstate Medical University | 1 |
| University of Washington | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Borderline Personality Disorder | 16 |
| Major Depressive Disorder | 3 |
| Alcoholism | 1 |
| Dysthymic Disorder | 1 |
| Personality Disorders | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.